Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

Cite

APA MLA Chicago

Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto. (2026, September 15). Toronto Star. https://www.thestar.com/globenewswire/quantum-biopharma-to-attend-the-arcstone-kingswood-growth-summit-2026-in-toronto/article_1d79869c-0466-5710-94b4-94f0cb21779d.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-09-15 · by GlobeNewswire, Inc.

Quick Summary

Quantum BioPharma Ltd., a biopharmaceutical company focused on developing treatments for neurodegenerative and metabolic disorders, will attend the ArcStone-Kingswood Growth Summit in Toronto on September 16, 2026. Anthony Durkacz, Co-founder and Executive Co-chairman of Quantum BioPharma, will discuss recent achievements and future plans during his presentation. Recently, the company received FDA approval for its Investigational New Drug application for Lucid-MS, a first-in-class multiple sclerosis treatment set to begin Phase 2 trials. The global MS therapeutics market is expected to reach $38.62 billion by 2030, according to Grand View Research.

Written by AI on 2026-09-16, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Quantum BioPharma Ltd., a biopharmaceutical company focused on treating neurodegenerative and metabolic disorders, will attend the 3rd Annual ArcStone-Kingswood Growth Summit in Toronto on September 16, 2026 at the Sheraton Center Toronto Hotel. Anthony Durkacz, co-founder and executive co-chairman of Quantum BioPharma, is scheduled to present on the company’s recent achievements and future plans. Recently, Quantum BioPharma announced that the U.S. Food and Drug Administration (FDA) had approved its Investigational New Drug application for Lucid-MS, enabling Phase 2 trials in progressive multiple sclerosis patients, an area with significant unmet medical needs globally.

Written for “Quantum BioPharma Conference Attendance” on 2026-11-01, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Quantum BioPharma Conference Attendance

Science · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.

Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing Different event

Toronto Star

Hedges 0 of 2 claims Outlet record 64/100

“Article A discusses Quantum BioPharma's attendance at a physical summit on September 16, while Article B refers to virtual investor forum presentations available for on-demand viewing on September 18.”

How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted

sentences that state something as happening or true

Uncertain

0 of 4 hedged ("reportedly", "may", "according to")

Leaning

not political

takes no side on a contested political question

Publisher signals

64/100

Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.

Outlets on this story

Science

Same framing elsewhere

articles that frame the event the way this one does

Analyzed 2026-09-16 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability

Source leaning vs. consistency

Publisher

Toronto Star · 10920 article(s) · 28 correction(s) detected

Running correction rate · 28 correction(s)

2026-10-31

Inmate's escape is just the latest problem for Tennessee's troubled prison system

2026-10-26

Correction

2026-10-24

Correction

2026-10-22

News Clarification for Oct. 22

2026-10-21

No. 6 Hoosiers try to for rare rebound at Michigan after turning the page on 22-game winning streak

2026-10-19

Driver’s License Suspensions for Court Debt Draw Scrutiny

2026-10-16

Amputations and cancer treatment delays: Lawmakers hear testimony on Mississippi prison healthcare

2026-10-16

UPDATE: Golconda Gold Releases Q3 2026 Production Update at Galaxy

2026-10-08

News Clarification for Oct. 8

2026-10-07

Correction

2026-10-05

Entertainment Correction for Oct. 5

2026-10-03

Tennessee's prisons chief is resigning after failed execution of Christa Pike

2026-09-28

Organizations call for Action to End the Deaths of Indigenous People in Custody

2026-09-27

Police memorial recognizes six officers killed in the line of duty in 2026

2026-09-27

UPDATE: WSP to host Power & Energy-focused investor event virtually only

2026-09-26

News Clarification for Sept. 27

2026-09-26

Former federal public servant seeks better pensions for injured workers

2026-09-25

News Corrections for Sept. 25

2026-09-25

She has not been charged. But the Project South allegations have branded her with a 'scarlet letter'

2026-09-24

Correction

2026-09-23

MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

2026-09-22

Costa Rican man complained of lack of care for diabetes before his death in ICE custody, family says

2026-09-22

Judges' grilling of accused men leads to sex assault and dangerous driving cases being overturned

2026-09-20

Jura Energy Corporation Provides Clarification Regarding Media Reports Concerning Its Petroleum Rights in Pakistan

2026-09-19

New details emerge about Toronto's guns-for-hire and the 'crash-out mission" that sparked the Project South investigation

2026-09-17

UPDATE: Osisko Critical Minerals Corporation Announces C$100 Million Private Placement of Special Warrants

2026-09-17

Alabama set to execute man for pawn shop killings months after his nitrogen gas execution blocked

2026-09-04

Orca Corrects Q3 Quarterly Dividend Announcement

Who wrote this

No reporter is named on this article, beyond the feed's “GlobeNewswire, Inc.”.

Topics

GLOBE NEWSWIRE QNTM Quantum BioPharma Quantum BioPharma Ltd. TORONTO

Subjects

Quantum BioPharma ORG · 3× TORONTO GPE · 2× 0K91 ORG · 1× Anthony Durkacz PERSON · 1× Company ORG · 1× FDA ORG · 1× GLOBE NEWSWIRE GPE · 1× QNTM ORG · 1× Quantum BioPharma Ltd. ORG · 1× the U.S. Food and Drug Administration ORG · 1×

Narrative

Quantum BioPharma Ltd. (NASDAQ: QNTM) (FSE: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, announces is pleased to announce its participation in the upcoming 3rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel.

framing: assertive · carried by 1 article(s) · first seen 2026-09-16

🔮 Anthony Durkacz, Co-founder and Executive Co-chairman of the board of Quantum BioPharma, will be presenting on the company’s recent milestones and future growth strategy.

2026-09-16 · Toronto Star

Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto · assertive framing

Claims (4 extracted, 0 hedged)

Ltd. → dedicate → Hotel

Anthony Durkacz, Co-founder and Executive Co-chairman of the board of Quantum BioPharma, will be presenting on the company’s recent milestones and future growth strategy. asserted

Durkacz → present → milestones

Recently Quantum BioPharma announced that the U.S. Food and Drug Administration (FDA) had approved its Investigational New Drug application for Lucid-MS, to begin Phase 2 trials for the very first time to advance its patented, first-in-class multiple sclerosis (“MS”) program in patients with progressive MS. asserted

Administration → announce → MS

This is currently an area of substantial unmet medical need within a global MS therapeutics market anticipated to reach approximately US$38.62 billion by 2030 (Grand View Research, 2026). asserted

This → anticipate → Research

💬Give feedback

🕘History 🎫Support

Terms · Privacy · beta v2.0.0

Articles to 1 Nov 2026